DPT / DTaP Vaccine

A combination vaccine protecting against diphtheria, pertussis (whooping cough), and tetanus. Available as whole-cell DPT (used in UIP) and acellular DTaP (used in private sector).

The DPT / DTaP Vaccine is recommended for 6 weeks, 10 weeks, 14 weeks (primary); 16–24 months (booster). It falls under the Childhood vaccine category. Consult your doctor to confirm if this vaccine is right for you based on your health history and existing immunity.

The DPT / DTaP Vaccine has an efficacy of 85–95%. This means it provides significant protection against Diphtheria and Pertussis (Whooping Cough). Efficacy may vary based on age, health status, and the specific strain encountered.

Common side effects include: Redness; swelling; tenderness at injection site; low-grade fever. These are typically mild and resolve within 1–3 days. Serious allergic reactions are rare — if you experience difficulty breathing, hives, or rapid heartbeat after vaccination, seek emergency care immediately.

The DPT / DTaP Vaccine should be avoided by: Encephalopathy within 7 days of prior dose; severe allergy to vaccine component. Always inform your healthcare provider of your full medical history before vaccination.

The DPT / DTaP Vaccine typically costs ₹50 – ₹800 in India. Government health centres may offer it free or at subsidised prices for eligible age groups. Private hospitals and clinics may charge differently. Additional fees may apply for administration.